期刊文献+

拉米夫定联合小剂量乙肝免疫球蛋白防止肝移植术后HBV感染的疗效分析 被引量:1

在线阅读 下载PDF
导出
摘要 目的探讨拉米夫定联合乙肝免疫球蛋白防止乙型肝炎相关肝病肝移植术后乙型肝炎病毒(HBV)再感染的效果。方法21例乙型肝炎相关肝病肝移植患者移植前后应用拉米夫定和乙肝免疫球蛋白预防HBV再感染,同时检测血清HBV标志物。结果21例肝移植者术后随访显示,6个月时HBV感染率为14.3%(3/21),12个月时为11.8%(2/17),24个月时为11.1%(1/9)。结论拉米夫定联合乙肝免疫球蛋白能有效地防止乙型肝炎相关肝病肝移植术后HBV再感染,有较好的费用-疗效比(cost-effective),值得进一步验证。
出处 《实用肝脏病杂志》 CAS 2006年第6期361-363,共3页 Journal of Practical Hepatology
  • 相关文献

参考文献9

  • 1ANSELMO DM, GHOBRIAL RM, JUNG LC, et al.New era of liver transplantation for hepatitis B. a 17-year single-center experience [J]. Ann Surg, 2002,235 (5) : 611-619.
  • 2LEE PH, HU RH, TSAI MK, et al. Liver transplantation for patient with hepatitis B, prevention of hepatitis B recurrence by intravenous anti- hepatitis B irnmunoglobulin and lamivudine[J]. Transplantation Proe, 2000,32.2245-2247.
  • 3ALl H, EGAWA H,URYUHARA K, et al. Prevention of hepatitis B virus recurrence after living donor liver transplantation[J]. Transplant Proc, 2004,36 (9) : 2764-2767.
  • 4中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14021
  • 5ANGUS PW, MCCAUGHAN GW, GANE EJ, et al.Combination low-dose hepatitis B immune globulin and lamlvudine therapy provides effective prophylaxis against posttransplantation hepatitis B[J]. Liver Transpl, 2000,6(4) 7429-433.
  • 6朱建平,李磊,张同琳,裴斐,庄辉.小剂量乙型肝炎免疫球蛋白与拉米夫定联合使用对肝移植术后乙肝复发的疗效[J].实用临床医药杂志,2003,7(3):239-242. 被引量:10
  • 7刘建,吴国聪,张忠涛,吴平,张栋,孙明昌,高东宸,王宇,贾继东,王宝恩.肝移植术后乙型肝炎复发的预防和治疗[J].中华外科杂志,2005,43(15):976-979. 被引量:15
  • 8PAOI.O DD, TISONE G, PICCOLO P, et al. Low-dose hepatitis B immunoglobulin given "on demand "in combination with lamivudine, a highly cost-effective approach to prenent recurrent hepalitls B virus infection in the long-term follow-up after liver transplantation[J]. Transplantation, 2004,77 (8):1203- 1208.
  • 9唐映梅 ,陈规划 ,何晓顺 ,朱晓峰 ,陈旻湖 .肝移植术后乙型肝炎病毒标志物动态变化谱及影响因素分析[J].中华肝脏病杂志,2005,13(3):164-167. 被引量:2

二级参考文献21

  • 1Sawyer R G, McGory R W, Galley M J, et al. Improved dinical outcomes with liver transplantation for hepatitis B induced chronic liver failure using passive immunization[J]. Ann Surg, 1998, 227(6): 841.
  • 2Markowitz J, Martin P, Conrad A, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin[J].Hepatology, 1998, 28(2): 585.
  • 3Carey W, Pimentel R, Westveer M K, et al. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial[J]. Am J Gastroenterol, 1990, 85(12):1590.
  • 4McMillan J S, Shaw T, Angus P W, et al. Effect of immuno-suppressive and antiviral agents on hepatitis B virus replication in vitro[J]. Hepatology, 1995, 22(1): 36.
  • 5Perrillo R, Rakela J, Dienstag J. Multicenter study of lamivudine therapy for hepatitis B after liver transplantation [ J ].Hepatology, 1999, 29(5): 1581.
  • 6Benari Z, Shmueli D, Mor E. Beneficial effect of Lamivudine in recurrent hepatitis B after liver transplantation[J]. Transplantation, 1997, 63: 393.
  • 7Liaw Y F, Chien R N, Yeh C T, et al. Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy[J]. Hepatology, 1999,30(2) : 567.
  • 8Samjuel D, Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients[J]. Lancet, 1991, 337(8745): 813.
  • 9Todo S, Demetris A J, Van Thiel D, et al. Orthotopie liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology, 1991, 13 : 619-626.
  • 10O'Grady JG, Smith HM, Davies SE, et al. Hepatitis B virus reinfection after orthotopic liver transplantation, serological and clinical implications. J Hepatol, 1992, 14 : 104-111.

共引文献14042

同被引文献17

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部